Association between the CTLA-4 +49A/G polymorphism and Graves' disease: A meta-analysis

Experimental and Therapeutic Medicine

Volumn 4, Issue 3, 2012, Pages 538-544

  Si, Xiaoyu ^a   Zhang, Xiufeng ^a   Tang, Wenru ^a   Luo, Ying ^a  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Autoimmune thyroid diseases; Cytotoxic T lymphocyte associated antigen 4 gene; Graves' disease; Meta analysis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HIGH RISK POPULATION; HUMAN; META ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 84863930632     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.618     Document Type: Article

References (50)

1. Wang C and Crapo LM: The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26: 189-218, 1997.
2. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA and Braverman LE: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87: 489-499, 2002.
3. Chen XWW, Chen GL, Zhang KZ, Zhang FL, et al: The effect of salt iodization for 10 years on the prevalences of endemic goiter and hyperthyroidism. Chin J Endocrinol Metab 18: 342-344, 2000.
4. Onodera T and Awaya A: Anti-thyroglobulin antibodies induced with recombinant reovirus infection in BALB/c mice. Immunology 71: 581-585, 1990.
5. Brix TH, Kyvik KO, Christensen K and Hegedus L: Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86: 930-934, 2001.
6. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y and Saruta T: CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7: 843-846, 1997.
7. Marron MP, Raffel LJ, Garchon HJ, et al: Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6: 1275-1282, 1997.
8. Donner H, Rau H, Walfish PG, et al: CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82: 143-146, 1997.
9. Veeramuthumari P, Isabel W and Kannan K: A Study on the level of T(3), T(4), TSH and the association of A/G polymorphism with CTLA-4 gene in Graves' hyperthyroidism among South Indian population. Ind J Clin Biochem 26: 66-69, 2011.
10. Zhao SX, Pan CM, Cao HM, et al: Association of the CTLA4 gene with Graves' disease in the Chinese Han population. PloS One 5: e9821, 2010.
11. Kimura H, Kato Y, Shimizu S, Takano K and Sato K: Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodaroneassociated thyroid dysfunction. Thyroid 19: 975-981, 2009.
12. Khalilzadeh O, Mojazi Amiri H, Tahvildari M, et al: Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy. Arch Dermatol Res 301: 719-723, 2009.
13. Esteghamati A, Khalilzadeh O, Mobarra Z, et al: Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients. Eur J Intern Med 20: 424-428, 2009.
14. Chong KK, Chiang SW, Wong GW, et al: Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest Ophthalmol Vis Sci 49: 2409-2415, 2008.
15. Wang PW, Chen IY, Liu RT, Hsieh CJ, Hsi E and Juo SH: Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study. J Clin Endocrinol Metab 92: 2513-2518, 2007.
16. Zhang Q, Yang YM and Lv XY: Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene. J Zhejiang Univ Sci B 7: 887-891, 2006.
17. Tanrikulu S, Erbil Y, Ademoglu E, et al: The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal. Endocrine 30: 377-381, 2006.
18. Han SZ, Zhang SH, Li R, Zhang WY and Li Y: The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients. Int J Immunogenet 33: 281-287, 2006.
19. Sahin M, Erdogan MF and Erdogan G: Cytotoxic T lymphocyteassociated molecule-4 polymorphisms in Turkish Graves' disease patients and association with probability of remission after antithyroid therapy. Eur J Intern Med 16: 352-355, 2005.
20. Petrone A, Giorgi G, Galgani A, et al: CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15: 232-238, 2005.
21. Wang PW, Liu RT, Juo SH, et al: Cytotoxic T lymphocyteassociated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal. J Clin Endocrinol Metab 89: 169-173, 2004.
22. Nakkash-Chmaisse H, Makki RF, Abdelhamid E, Fakhoury H, Salti NN and Salti I: CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population. Eur J Immunogenet 31: 141-143, 2004.
23. Vaidya B, Oakes EJ, Imrie H, Dickinson AJ, Perros P, Kendall- Taylor P and Pearce SH: CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin Endocrinol 58: 732-735, 2003.
24. Mochizuki M, Amemiya S, Kobayashi K, et al: Association of the CTLA-4 gene 49A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 26: 843-847, 2003.
25. Kalantari T, Mostafavi H, Pezeshki AM, Farjadian S, Doroudchi M, Yeganeh F and Ghaderi A: Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' disease. Autoimmunity 36: 313-316, 2003.
26. Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M and Nauman J: Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. European J Endocrinol 148: 13-18, 2003.
27. Yung E, Cheng PS, Fok TF and Wong GW: CTLA-4 gene A-G polymorphism and childhood Graves' disease. Clin Endocrinol 56: 649-653, 2002.
28. Kouki T, Gardine CA, Yanagawa T and Degroot LJ: Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J Endocrinol Invest 25: 208-213, 2002.
29. Kinjo Y, Takasu N, Komiya I, et al: Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. J Clin Endocrinol Metab 87: 2593-2596, 2002.
30. Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M and Ayadi H: CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease. Clin Immunol 101: 361-365, 2001.
31. Park YJ, Chung HK, Park DJ, Kim WB, Kim SW, Koh JJ and Cho BY: Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10: 453-459, 2000.
32. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML and DeGroot LJ: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165: 6606-6611, 2000.
33. Chistyakov DA, Savost'anov KV, Turakulov RI, et al: Complex association analysis of Graves disease using a set of polymorphic markers. Mol Genet Metab 70: 214-218, 2000.
34. Heward JM, Allahabadia A, Armitage M, et al: The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 84: 2398-2401, 1999.
35. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH and Badenhoop K: CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51: 563-566, 1998.
36. Awata T, Kurihara S, Iitaka M, et al: Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47: 128-129, 1998.
37. Kimkong I, Nakkuntod J, Sae-Ngow S, Snabboon T, Avihingsanon Y and Hirankarn N: Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population. Asian Pac J Allergy Immunol 29: 229-235, 2011.
38. Namo Cury A, Longui CA, Kochi C, et al: Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism. Horm Res 70: 36-41, 2008.
39. Cho HJ, Chung JH, Kim IS, Kim HJ, Cho SH, Ki CS and Kim JW: Lack of a genetic association between the CTLA-4 gene and Graves' disease in Koreans. Thyroid 16: 237-241, 2006.
40. Weng YC, Wu MJ and Lin WS: CT60 single nucleotide polymorphism of the CTLA-4 gene is associated with susceptibility to Graves' disease in the Taiwanese population. Ann Clin Lab Sci 35: 259-264, 2005.
41. Iwama S, Ikezaki A, Kikuoka N, et al: Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children. Horm Res 63: 55-60, 2005.
42. Frydecka I, Daroszewski J, Suwalska K, et al: CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region. Arch Immunol Ther Exp (Warsz) 52: 369-374, 2004.
43. Allahabadia A, Heward JM, Nithiyananthan R, et al: MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 358: 984-985, 2001.
44. Villanueva R, Inzerillo AM, Tomer Y, et al: Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid 10: 791-798, 2000.
45. *0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab 85: 1545-1549, 2000.
46. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, et al: No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 47: 125-127, 1998.
47. DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.
48. Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959.
49. Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997.
50. Schneider H, Downey J, Smith A, et al: Reversal of the TCR stop signal by CTLA-4. Science 313: 1972-1975, 2006.